At 29.6% CAGR, the Europe Vitamin K2 Market is projected to be worth US$ 423.10 million by 2030, says Business Market Insights

According to Business Market Insights research, the Europe vitamin K2 market was valued at US$ 53.27 million in 2022 and is expected to reach US$ 423.10 million by 2030, registering a CAGR of 29.6% from 2022 to 2030. Regulatory consideration and standards and expansion of distribution channel are among the critical factors attributed to the Europe vitamin K2 market expansion.

Expanding the distribution channels for vitamin K2 can help improve the accessibility of this essential nutrient to a broader population. To effectively expand the distribution channels for vitamin K2, it is necessary to collaborate with various stakeholders-including manufacturers, wholesalers, retailers, and online platforms. Working closely with manufacturers ensures increased production and supply of vitamin K2 products to meet the growing demand. The distribution of these items to merchants in pharmacies, health shops, supermarkets, and specialty supplement stores, can be made easier by forming relationships with wholesalers. Additionally, customers can be made aware of the value of vitamin K2 by viewing product displays and educational materials at retail locations. Also, it is critical to work with developing economies-based e-commerce companies and web-based platforms to provide customers with a simple way to buy supplements and other items containing vitamin K2 online.

Furthermore, encouraging the inclusion of vitamin K2 in everyday meals and drinks can broaden the market for supplements, making it more available to people preferring a nutritional diet. Working with healthcare experts such as doctors, nutritionists, and dietitians is also essential, as these experts can advise patients to take vitamin K2 supplements and recommend a store to buy the product. This is raising the demand for vitamin K2. Thus, the expansion of the distribution networks through medical channels is expected to provide ample opportunities for market growth in the coming years.

On the contrary, limited awareness regarding benefits of vitamin K2 hampers the Europe vitamin K2 market.

Based on product, the Europe vitamin K2 market is segmented into MK-4, MK-7, and combination drugs. The MK-7 segment held 64.3% share of Europe vitamin K2 market in 2022, amassing US$ 34.26 million. It is projected to garner US$ 276.94 million by 2030 to expand at 29.9% CAGR during 2022-2030.

Based on dosage forms, the Europe vitamin K2 market is segmented into capsules & tablets, powder, and oils. The powder segment held 56.5% share of Europe vitamin K2 market in 2022, amassing US$ 30.11 million. It is projected to garner US$ 247.44 million by 2030 to expand at 30.1% CAGR during 2022-2030.

Based on source, the Europe vitamin K2 market is segmented into natural and synthetic. The natural segment held 83.6% share of Europe vitamin K2 market in 2022, amassing US$ 44.54 million. It is projected to garner US$ 357.07 million by 2030 to expand at 29.7% CAGR during 2022-2030.

Based on application, the Europe vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. The pharmaceuticals segment held 67.0% share of Europe vitamin K2 market in 2022, amassing US$ 35.68 million. It is projected to garner US$ 277.57 million by 2030 to expand at 29.2% CAGR during 2022-2030.

Based on country, the Europe vitamin K2 market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 29.3% share of Europe vitamin K2 market in 2022. It was assessed at US$ 15.60 million in 2022 and is likely to hit US$ 120.88 million by 2030, exhibiting a CAGR of 29.2% during 2022-2030.

Key players operating in the Europe vitamin K2 market are Anderson Global Group LLC, Balchem Corp, BASF SE, Glanbia Plc, International Flavors & Fragrances Inc, Koninklijke DSM NV, Lesaffre et Cie SA, Lonza Group AG, and Novozymes AS, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com